{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (2''R'',3''E'',5''S'',8''R'',9''S'',10''S'',13''S'',14''S'',17''S'')-2-Chloro-10,13-dimethyl-3-(4-nitrophenoxy)imino-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[''a'']phenanthren-17-ol
| image = Nisterime.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 51354-32-6
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 5361123
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 4514747
| UNII = ABF7S9U8W6
| KEGG = 
| ChEBI = 
| ChEMBL = 

<!--Chemical data-->
| C=25 | H=33 | Cl=1 | N=2 | O=4
| SMILES = C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@]3(C[C@H](/C(=N/OC5=CC=C(C=C5)[N+](=O)[O-])/C4)Cl)C
| StdInChI_Ref = 
| StdInChI = 1S/C25H33ClN2O4/c1-24-12-11-20-18(19(24)9-10-23(24)29)8-3-15-13-22(21(26)14-25(15,20)2)27-32-17-6-4-16(5-7-17)28(30)31/h4-7,15,18-21,23,29H,3,8-14H2,1-2H3/b27-22+/t15-,18-,19-,20-,21+,23-,24-,25-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = FSSASQYIDSGHST-BWYVWVFTSA-N
| synonyms = <small>2α-Chloro-5α-androstan-17β-ol-3-one ''O''-(''p''-nitrophenyl)oxime; 2α-Chloro-4,5α-dihydrotestosterone ''O''-(''p''-nitrophenyl)oxime; 2α-Chloro-3-(''p''-nitrophenoxy)imino-5α-androstan-17β-ol</small>
}}

'''Nisterime''' ([[International Nonproprietary Name|INN]]), also known as '''2α-chloro-4,5α-dihydrotestosterone ''O''-(''p''-nitrophenyl)oxime''' or as '''2α-chloro-5α-androstan-17β-ol-3-one ''O''-(''p''-nitrophenyl)oxime''', is a [[synthetic compound|synthetic]] [[anabolic-androgenic steroid]] (AAS) and a [[chemical derivative|derivative]] of [[dihydrotestosterone]] (DHT) that was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA876|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=876–}}</ref> The C17α [[acetate]] [[ester]] of nisterime, [[nisterime acetate]] (ORF-9326), also exists and was developed as a [[postcoital contraceptive]] but was similarly never marketed.<ref name="Elks2014" />

==See also==
* [[Istaroxime]]

==References==
{{Reflist}}

{{Androgen receptor modulators}}

[[Category:Alcohols]]
[[Category:Androgens and anabolic steroids]]
[[Category:Androstanes]]
[[Category:Hormonal contraception]]
[[Category:Nitrobenzenes]]
[[Category:Organochlorides]]
[[Category:Oximes]]
[[Category:Abandoned drugs]]

{{steroid-stub}}
{{genito-urinary-drug-stub}}